Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 496161 - 496180 out of 498419 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| USA | (L01EX27) capivasertib | TRUQAP 160MG TAB | 64 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | ASTRAZENECAPHARMACEUTICALSLP |
| USA | (L01EX27) capivasertib | TRUQAP 160MG TAB | 64 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | ASTRAZENECAPHARMACEUTICALSLP |
| USA | (L01EX27) capivasertib | TRUQAP 160MG TAB | 4x16 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | ASTRAZENECAPHARMACEUTICALSLP |
| USA | (L01EX27) capivasertib | TRUQAP 200MG TAB | 4x16 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | ASTRAZENECAPHARMACEUTICALSLP |
| USA | (L01EX27) capivasertib | TRUQAP 200MG TAB | 64 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | ASTRAZENECAPHARMACEUTICALSLP |
| USA | (L01EX27) capivasertib | TRUQAP 200MG TAB | 64 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | ASTRAZENECAPHARMACEUTICALSLP |
| USA | (L01EX27) capivasertib | TRUQAP 200MG TAB | 4x16 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | ASTRAZENECAPHARMACEUTICALSLP |
| USA | (L01EX28) repotrectinib | AUGTYRO 40MG CAP,ORAL | 120 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung;Cancer | Bristol-MyersSquibbCompany |
| USA | (L01EX28) repotrectinib | AUGTYRO 40MG CAP,ORAL | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung;Cancer | Bristol-MyersSquibbCompany |
| USA | (L01FD07) zanidatamab | ZIIHERA 300MG/VIAL INJ | 2 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | JazzPharmaceuticals,Inc. |
| USA | (L01FF01) nivolumab | OPDIVO QVANTIG | 5ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | Bristol-MyersSquibbCompany |
| USA | (L01FF03) durvalumab | IMFINZI 120MG INJ | 120MG | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | ASTRAZENECAPHARMACEUTICALSLP |
| USA | (L01FF03) durvalumab | IMFINZI 120MG INJ | 120MG | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | ASTRAZENECAPHARMACEUTICALSLP |
| USA | (L01FF03) durvalumab | IMFINZI 500MG INJ | 500MG | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | ASTRAZENECAPHARMACEUTICALSLP |
| USA | (L01FF03) durvalumab | IMFINZI 500MG INJ | 500MG | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | ASTRAZENECAPHARMACEUTICALSLP |
| USA | (L01FF09) tislelizumab | TEVIMBRA 10MG/ML INJ,SOLN | 10ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Esophageal Squamous Cell Carcinoma | BeiGeneUSA,Inc. |
| USA | (L01FF09) tislelizumab | TEVIMBRA 10MG/ML INJ,SOLN | 10ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Esophageal Squamous Cell Carcinoma | BeiGeneUSA,Inc. |
| USA | (L01FX06) dinutuximab beta | UNITUXIN 3.5MG/ML INJ | 5ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | UnitedTherapeuticsCorporation |
| USA | (L01FX06) dinutuximab beta | UNITUXIN 3.5MG/ML INJ | 5ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | UnitedTherapeuticsCorporation |
| USA | (L01FX20) tremelimumab | IMJUDO 20MG/ML INJ | 1.25ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Hepatocellular;Carcinoma, Non-Small-Cell Lung | ASTRAZENECAPHARMACEUTICALSLP |
Pages
